Institution: | (1) National Corporation of Swedish Pharmacies (Apoteket AB), SE-118 81 Stockholm, Sweden;(2) Swedish Pharmaceutical Benefits Board (LFN), Stockholm, Sweden;(3) Karolinska Institutet, Centre for Pharmacoepidemiology and Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden;(4) Karolinska Institutet, Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital, Stockholm, Sweden |